INT228103
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Its involvement in the function of endothelial cells has also been illustrated by the activation of Rac1 under flow and shear stress [23]. | |||||||||||||||
| |||||||||||||||
|
Several studies have shown that VEGF-mediated endothelial cell migration in 2D involves activation of Rac1 [38], [39], [40] and our data are in line with these observations. | |||||||||||||||
| |||||||||||||||
|
Regarding proliferation, our results corroborate the findings that increased Rac1 activity correlates with enhanced endothelial proliferation, since the elevated Rac1-activity in ? | |||||||||||||||
| |||||||||||||||
|
To verify that tamoxifen treatment of Rac1 flox/flox PDGFB-iCreER endothelial cells induced Rac1-deletion, endothelial cells and non-endothelial cells were isolated from Rac1 flox/flox PDGFB-iCreER mice and treated with tamoxifen (OHT) or ethanol (vehicle) in culture. | |||||||||||||||
| |||||||||||||||
|
This vector allows tissue-specific activation of Rac1 short hairpin RNA (shRNA) in Cre-expressing cells in vivo. | |||||||||||||||
| |||||||||||||||
|
In contrast, recent studies have suggested a positive role for Rac1 in endothelial cell function. | |||||||||||||||
| |||||||||||||||
|
Our data also illustrate that the requirement for Rac1 in 3D versus 2D endothelial cell migration is different. | |||||||||||||||
| |||||||||||||||
|
RhoA, Cdc42 and Rac1 can be activated when GTP-bound, and inactivated, when GDP-bound. | |||||||||||||||
| |||||||||||||||
|
Although recent work has shown that molecules such as RhoG can compensate for Rac-1 [51] there is also evidence that this depends on specific signaling cascades and is not always the case [52]. | |||||||||||||||
| |||||||||||||||
|
Rac1 is not required for VEGF-mediated angiogenesis in wild-type mice but is in ? | |||||||||||||||
| |||||||||||||||
|
Vania Braga, Imperial College, London, UK), was used to pull down active Rac1 and Cdc42 from MLEC cell lysates transfected with scrambled or Rac1 siRNA. | |||||||||||||||
| |||||||||||||||
|
Given that VEGF is a key positive regulator of pathological angiogenesis and that VEGF/VEGFR2 signalling is known to activate Rac1 in vitro, we tested the effect of endothelial-specific Rac1-depletion on VEGF-mediated neovascularization in vivo. | |||||||||||||||
| |||||||||||||||
|
To confirm that the observed effect of simvastatin on RhoA and Rac1 activation was due to a shortage of GGPP, we studied the effect of GGTI, an inhibitor of geranylgeranyl transferase, on localization and activation of RhoA and Rac1 and found that GGTI had a similar effect as simvastatin. | |||||||||||||||
| |||||||||||||||
|
After treatment with GGTI, Rac1 was also activated in MKD cells; however, no Rac1 activation was detected in control cells (Fig. 2j). | |||||||||||||||
| |||||||||||||||
|
In summary, we showed that protein isoprenylation in MKD cells is more sensitive to inhibition by simvastatin than in control cells, resulting in an increased, ectopic activation of soluble RhoA and Rac1 in MKD cells. | |||||||||||||||
| |||||||||||||||
|
The relative increase in active RhoA was larger than the relative increase in active Rac1 (Fig. 1e, j).
| |||||||||||||||
| |||||||||||||||
|
Because small GTPases depend on isoprenylation for their proper signalling function, we studied the effect of MK deficiency on isoprenylation (i.e., geranylgeranylation) and activation of the two small GTPases, RhoA and Rac1. | |||||||||||||||
| |||||||||||||||
|
After treatment with GGTI, Rac1 was also activated in MKD cells; however, no Rac1 activation was detected in control cells (Fig. 2j). | |||||||||||||||
| |||||||||||||||
|
Incubation with GGTI led to a reduction in membrane-bound RhoA and Rac1 that was similar for both control and MKD cells (Fig. 2b, g) and, in parallel, an increase in the levels of soluble RhoA and Rac1 (Fig. 2c and 2h). | |||||||||||||||
| |||||||||||||||
|
The increase in total cellular levels of active RhoA and Rac1 due to simvastatin appears primarily, if not solely, caused by activation of soluble RhoA and Rac1 and not membrane-bound RhoA and Rac1. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.